Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation

Posaconazole (PCZ) is frequently used for prophylaxis against invasive fungal infections (IFI) in patients undergoing induction chemotherapy for acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Posaconazole is commercially available as an oral suspension (PCZ-susp) and as a delayed-re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Leuk Res Treatment
Autori principali: Belling, Morgan, Kanate, Abraham S., Shillingburg, Alexandra, Lu, Xiaoxiao, Wen, Sijin, Shah, Nilay, Craig, Michael, Cumpston, Aaron
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485328/
https://ncbi.nlm.nih.gov/pubmed/28695013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3460892
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi